$COGT has generated 19 mentions from 2 distinct FinTwit voices over the past 12 months, with the first mention appearing on 2025-06-20. Jacob Plieth (@jacobplieth) accounts for 17 of these mentions, establishing him as the dominant voice discussing Cogent Biosciences, while Adam Feuerstein (@adamfeuerstein) contributed 2 mentions. The biotech sector has been the primary category of discussion for this ticker.

The most recent activity occurred on 2026-03-27, with Jacob Plieth posting about potential product strategy shifts. Discussion centered on competitive developments in kinase inhibition therapies, with Plieth noting comparisons between $COGT and other biotechs pursuing similar therapeutic approaches. The final mention from Plieth on 2026-03-27 referenced market movement in related securities alongside $COGT.